Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date | Reported DateTime | Company | Symbol | Insider Relationship | Shares Traded | Average Price | Total Amount | Shares Owned | Filing |
| 2023-02-15 Sale | 2023-02-16 08:47 am | CONCERT PHARMACEUTICALS INC. | CNCE | Becker Marc A. Chief Financial Officer | 3,762 | $8.33 | $31,337 | 123,863 (Direct) | View |
| 2023-01-30 Sale | 2023-01-31 08:27 am | CONCERT PHARMACEUTICALS INC. | CNCE | Becker Marc A. Chief Financial Officer | 8,493 | $8.35 | $70,917 | 127,625 (Direct) | View |
| 2023-01-06 Sale | 2023-01-09 4:12 pm | CONCERT PHARMACEUTICALS INC. | CNCE | Becker Marc A. Chief Financial Officer | 2,893 | $7.25 | $20,974 | 136,118 (Direct) | View |
| 2022-02-14 Sale | 2022-02-16 08:00 am | CONCERT PHARMACEUTICALS INC. | CNCE | Becker Marc A. Chief Financial Officer | 3,762 | $3.08 | $11,587 | 139,011 (Direct) | View |
| 2022-01-05 Sale | 2022-01-07 4:17 pm | CONCERT PHARMACEUTICALS INC. | CNCE | Becker Marc A. Chief Financial Officer | 2,894 | $3.2 | $9,261 | 61,173 (Direct) | View |
| 2021-08-16 Sale | 2021-08-17 4:01 pm | CONCERT PHARMACEUTICALS INC. | CNCE | Becker Marc A. Chief Financial Officer | 7,304 | $3.28 | $23,957 | 64,067 (Direct) | View |
| 2021-02-16 Sale | 2021-02-17 9:21 pm | CONCERT PHARMACEUTICALS INC. | CNCE | Becker Marc A. Chief Financial Officer | 3,763 | $7.32 | $27,545 | 71,371 (Direct) | View |
| 2020-08-17 Sale | 2020-08-19 5:43 pm | CONCERT PHARMACEUTICALS INC. | CNCE | Becker Marc A. Chief Financial Officer | 2,875 | $10.24 | $29,440 | 53,434 (Direct) | View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date | Reported DateTime | Exercisable Expiration | Company | Symnbol | Insider Relationship | Shares Traded | Conversion Price | Shares Owned | Filing |
| 2023-03-06 Disposition | 2023-03-06 11:35 am | N/A N/A | CONCERT PHARMACEUTICALS INC. | CNCE | Becker Marc A. Chief Financial Officer | 371,879 | $0 | 0 (Direct) | View |
| 2023-03-06 Equity Swap | 2023-03-06 11:35 am | N/A N/A | CONCERT PHARMACEUTICALS INC. | CNCE | Becker Marc A. Chief Financial Officer | 56,264 | $0 | 0 (Direct) | View |
| 2022-01-28 Option Award | 2022-02-01 4:02 pm | N/A N/A | CONCERT PHARMACEUTICALS INC. | CNCE | Becker Marc A. Chief Financial Officer | 81,600 | $0 | 142,773 (Direct) | View |
| 2021-01-05 Option Award | 2021-01-07 4:32 pm | N/A 2031-01-04 | CONCERT PHARMACEUTICALS INC. | CNCE | Becker Marc A. Chief Financial Officer | 73,550 | $0 | 126,984 (Direct) | View |
| 2020-02-14 Option Award | 2020-02-19 4:03 pm | N/A 2030-02-13 | CONCERT PHARMACEUTICALS INC. | CNCE | Becker Marc A. Chief Financial Officer | 70,646 | $0 | 98,739 (Direct) | View |